Demographic and Behavioural Factors Associated with Uptake of at least Three Doses of Intermitted Preventive Treatment of Malaria in Pregnancy (IPTp-SP3) among Nigerian Women

Download Article

DOI: 10.21522/TIJPH.2013.06.01.Art009

Authors : Mathew Okoh, Babalola S, McCartney-Melstad A, Tweedie I, Amosu, A. M

Abstract:

Malaria is a vector borne protozoa disease that is endemic in Nigeria and continues to present significant public health challenge to the Nigerian government. Pregnant women are especially vulnerable to malaria infection due to their compromised immunity. Malaria contributes significantly to poor pregnancy outcomes like low birth weight, premature delivery, still birth, spontaneous abortion and neonatal death.

The use of IPTp-SP has been proven to be a safe, cheap and effective means to prevent malaria and its consequences among pregnant women. Consequently, pregnant women are expected to receive a minimum of three doses of IPTp-SP beginning from the 13th week of pregnancy. In spite of this, uptake of IPTp-SP by pregnant women still remains low in Nigeria.

This research investigated the demographic and behavioural factors that were associated with uptake of at least three doses of IPTp-SP among women who had a live birth in the two years preceding the survey. The study was quantitative in design and used cross sectional data that included 3205 women from Akwa Ibom, Kebbi and Nasarawa states.

Findings from this study suggest that ANC attendance is the most important factor associated with uptake of a minimum of three doses of IPTp-SP (IPTp-SP3). This might not be unconnected to the IPTp-SP strategy being largely a facility based intervention. Household wealth index exhibited a marginally significant relation with uptake of IPTp-SP3. After adjusting for cluster level effects and other potential confounders, a woman’s decision making autonomy and state where she was resident were found to be significantly associated with uptake of IPTp-SP3. An unexpected but logical finding was the inverse relationship between regular use of bed net and uptake of IPTp-SP3. This finding has implication for how bed net use is presented to pregnant women.

Results from this study suggests that, improved access to ANC services, improved women’s autonomy , and educating pregnant women that regular bed net use does not preclude the need for IPTp-SP utilization could go a long way in improving uptake of IPTp-SP among pregnant women in Nigeria.

Keywords: Malaria, Pregnancy, Ante natal care, IPTP-SP, Behaviour, Nigeria.

References:

[1]. Adhikar, R. (2016). Effect of Women’s autonomy on maternal health service utilization in Nepal: a cross sectional study. BMC Women's Health 16:26. DOI 10.1186/s12905-016-0305-7. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867085/. Accessed June 26 2017

[2]. Akinleye SO, Falade CO, Ajayi IO. (2009). Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study. BMC Pregnancy Childbirth, 9:28.

[3]. Amoran, O.E., Ariba, A.A., & Iyaniwura, C.A. (2012). Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reproductive Health, 9:12. Available from http://www.reproductive-health-journal.com/content/9/1/12 Accessed June 11 2015

[4]. Aziken, M.E., Akubuo, K.K., & Gharoro E.P. (2011). Efficacy of intermittent preventive treatment with sulfadoxine–pyrimethamine on placental parasitemia in pregnant women in Midwestern Nigeria. Int J of Gyne obs, 112 (1) 30-33

[5]. Bloom, S.S., Wypij, D., Gupta, M.D. (2001). Dimensions of Women’s Autonomy and the Influence on Maternal Health Care Utilization in a North Indian City. Demography, 38(1), 67–78.

[6]. Bouyou-Akotet, M., K., Mawili-Mboumba, D., P., & Kombila, M. (2013). Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon. BMC Pregnancy and Childbirth, 13:52 Available from http://www.biomedcentral.com/1471-2393/13/52. Accessed November 28 2017

[7]. Brieger W. (2012). Control of malaria in pregnancy: an elusive target. Afr Health. 34:15–18

[8]. Exavery, A., Mbaruku, G., Mbuyita, S., Makemba, A., Kinyonge, I.P., & Kweka, H. (2014). Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania. Malaria Journal, 13:22. Available from http://www.malariajournal.com/content/13/1/22. Assessed December 27 2015.

[9].     Federal Ministry of Health. (2014). National Guidelines and Strategies for Malaria Prevention and Control during Pregnancy. Second Edition Federal Ministry of Health, Nigeria.

[10].  Filmer, D. and Pritchett, L.H. (2001). Estimating wealth effects without expenditure data or tears: an application to educational enrollment in states of India. Demography 38, 115-132.

[11].  Fokam, E.B., Ngimuh, L., Anchang‑Kimbi, J.K., & Wanji, S. (2016). Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon. Malar J 15:172 DOI 10.1186/s12936-016-1228-3. Available from https://malariajournal.biomedcentral.com/articles/10.1186/s12936-016-1228-3. Accessed July 1 2017

[12].  Hill, J., Hoyt, J., van Eijk, A.M., D’Mello-Guyett, L., ter Kuile, F.O., Stekette, R., Smith, H., & Webster, J. (2013). Factors Affecting the Delivery, Access, and Use of Interventions to Prevent Malaria in Pregnancy in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Plos ONE 10(7) e1001488. https://doi.org/10.1371/journal.pmed.1001488. Available from http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001488. Accessed June 26 2017

[13].  Hughes, A. (2011). Methods to protect pregnant women from malaria are still under-utilized in Sub-Saharan Africa. Medical News Today. Available from http://www.medicalnewstoday.com/printerfriendlynews.php?newsid. Accessed 20 Nov 2016.

[14].  Kibusi, S.M., Kimunai, E., & Hines, C.S. (2015). Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania. BMC Public Health 15:540 DOI 10.1186/s12889-015-1905-0

[15].  Mahapatro, SR. (2012). Utilization of Maternal and Child Health Care Services in India: Does women’s autonomy matter? The Journal of Family Welfare Vol. 58, No.1 22-33.

[16].  Mistry, R., Galal, O., Lu, M. (2009). ‘‘Women’s autonomy and pregnancy care in rural India: A contextual analysis’’ Social Science & Medicine 69; 926–933.

[17].  Marchant, T., Armstrong-Schellenberg, J., Nathan, R., Abdulla, S., Mukasa, O., Mshinda, H., & Lengeler, C. (2004). Anaemia in pregnancy and infant mortality in Tanzania.Trop Med Int Health, 9 (2):262-266

[18].  Mbonye, A.K., Bygbjerg, I.B., Magnussen, P. (2008). Intermittent preventive treatment of malaria in pregnancy: A community based delivery-system and its effects on parasitaemia, anaemia and low birth weight in Uganda. Int J Infect Dis, 2:22–29.

[19].  McGready, R., Lee, S.J., Wiladphaingern, J., Ashley, E.A., Rijken, M.J., Boel, M., …Nosten, F.H. (2012). Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis, 12: 388–396.

[20].  McGready R., White N., Nosten F. (2011). Parasitological efficacy of antimalarials in the treatment and prevention of falciparum malaria in pregnancy 1998 to 2009: a systematic review. BJOG ;118:123–135

[21].  Mutulei, A.C.N. (2013).Factors Influencing the Uptake of Intermittent Preventive Treatment for Malaria in Pregnancy: Evidence from Bungoma East District, Kenya. American Journal of Public Health Research, 1(5), 110-123 Available from http://pubs.sciepub.com/ajphr/1/5/2. Accessed June 26 2017.

[22].  National Malaria Elimination Programme (NMEP), National Population Commission (NPoPC), National Bureau of Statistics (NBS), & ICF International. 2016). Nigeria Malaria Indicator Survey 2015: Key Indicators. Abuja, Nigeria, and Rockville, Maryland, USA: NMEP, NPoPC, and ICF International.

[23].  Nayak S., Varambally, K.V.M. (2017). Impact of Autonomy on Health-seeking Behaviour: Evidence from Rural India. Journal of Health Management 19(1) 109–120 DOI: 10.1177/0972063416682889

[24].  Nduka FO, Nwosu E, Oguariri RM. (2011). Evaluation of the effectiveness and compliance of IPTp in the control of malaria in pregnant women in southeastern Nigeria. Ann Trop Med Parasitol, 105:599–605.

[25].  Nganda, R.Y., Drakeley, C., Reyburn, H., & Marchant, T. (2004). Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania. Malaria Journal, 3:42 doi: 10.1186/1475-2875-3-42. Available from: http://www.malariajournal.com/content/3/1/42. Accessed June 20 2015.

[26].  Olukemi, T.O., Emmanuel, O.A., & Olusina, A.O. (2009).The use of intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnancy in Ibadan, Nigeria: Implications for policy. Journal of Public Health and Epidemiology 1(1) 001-006.

[27].  Onoka, C.A., Hanson, K., Onwujekwe, O. E. (2012). Low coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: demand-side influences. . Malaria Journal, 11:82. Available from http://www.malariajournal.com/content/11/1/82. Accessed September 14 2016.

[28].  Owusu‑Boateng, I., & Anto, F. (2017). Intermittent preventive treatment of malaria in pregnancy: a crosssectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana. Malar J 16:323 DOI 10.1186/s12936-017-1969-7.

[29].  Peter, A.O. (2013). Effect of intermittent preventive treatment of malaria on the outcome of pregnancy among women attending antenatal clinic of a new Nigerian teaching hospital, Ado-Ekiti. Niger Med J, 54(3): 170–175. doi: 10.4103/0300-1652.114582.

[30].  Russell, T.L., Beebe, N.W., Cooper, R.D., Lobo, N.F., & Burkot, T.R. (2013). Successful malaria elimination strategies require interventions that target changing vector behaviours. Malaria Journal, 12:56. Available from http://www.malariajournal.com/content/12/1/56. Accessed August 12 2017.

[31].  Shulman, C.E., Graham, W.J., Jilo, H., Lowe, B.S., New, L., Obiero, J., … Marsh, K. (1996). Malaria as an important cause of anemia in primigravidae: evidence from a district hospital in coastal Kenya. Trans R Soc Trop Med Hyg, 90:535-539.

[32].  Sikambale, C., Halwindi, H., & Baboo, K.S. (2013). Factors Influencing Utilization of Intermittent Presumptive Treatment of Malaria (IPTp) Services by Pregnant Women in Sesheke District of Western Province Zambia. Medical Journal of Zambia, 40 (1) 24-32.

[33].  Sokhna, C., Ndiath, M.O., & Rogier, C. (2013). The changes in mosquito vector behaviour and the emerging resistance to insecticides will challenge the decline of malaria. Clin Microbiol Infect; 19: 902–907.

[34].  Steketee, R.W., Wirima, J.J., & Campbell, C.C., (1996). Developing effective strategies for malaria prevention programmes for pregnant African women. American journal of tropical medicine and hygiene, 55 (1 Suppl): 95–100.

[35].  Takem, E.N., Achidi, E.A., Ndumbe, P.M. (2009). Use of intermittent preventive treatment for malaria by pregnant women in Beua, Cameroon. Acta Trop, 112:54–58.

[36].  Thomsen, E.K., Koimbu, G., Pulford, J., Jamea-Maiasa, S., Ura, Y., Keven, J.B., … Reimer, L.J. (2017).Mosquito Behavior Change After Distribution of Bed nets Results in Decreased Protection Against Malaria Exposure. The Journal of Infectious Diseases, 215:790–7.

[37].  Verhoeff, F.H., Brabin, B.J., Chimsuku, L., Kazembe, P., Russel, W.B., & Broadhead, R.L. (1998). An evaluation of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birth weight in rural Malawi. Ann Trop Med Parasitol, 92:141-150.

[38].  Woldemicael, G. (2007). Do women with higher autonomy seek more maternal and child health-care? Evidence from Ethiopia and Eritrea. Available from http://www.demogr.mpg.de/papers/working/wp-2007-035.pdf. Accessed June 26 2017.

[39].  World Health Organization (2011). WHO Global Malaria Programme: World Malaria Report. World Health Organization, Geneva, Switzerland.

[40].  World Health Organization. (2014). WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) April 2013 (rev. January 2014).

[41].  World Health Organization. (2017). Malaria in pregnant women. Available from http://www.who.int/malaria/areas/high_risk_groups/pregnancy/en/. Accessed November 10 2017.

[42].  World Health Organization &United Nations International Children Education Fund. (2003). Malaria in pregnancy. World Health Organization/UNICEF. WHO/CDS/MAL/2003. 1093.